In conclusion, our study demonstrated that IP administration of LMWH could improve peritoneal function and relieve peritoneal fibrosis, possibly through suppression of HIF-1α, VEGF and TGF-β1. The gene discussed is HIF1A; the disease is Peritoneal Fibrosis.